Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Disease area: Paediatric lung diseases, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
M.C. Stam, H.W. de Valk, E.A. van de Graaf (Utrecht, Netherlands). Adults with cystic-fibrosis related diabetes have lower pulmonary function and more infections. Eur Respir J 2012; 40: Suppl. 56, 1114

Member's Comments

No comment yet.

Related content which might interest you: Selection of a gene panel related to pulmonary hypertension associated with respiratory diseases Source: Virtual Congress 2021 – Non-pulmonary arterial hypertension pulmonary hypertension Year: 2021 Screening for hickman line related infection in patients with severe pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 582s Year: 2003 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Prognostic value of right ventricular function in patients with severe pulmonary hypertension associated with respiratory disease Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013 Cystic fibrosis related diabetes (CFRD) and diabetic control as a determinant of pulmonary function: fact or fiction? Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health Year: 2008 CF related diabetes Source: ERS course 2015 Year: 2015 Variation in mortality from pulmonary hypertension by aetiology Source: International Congress 2015 – Pulmonary hypertension: management Year: 2015 Structural lung disease, pulmonary infection and inflammation in infancy is associated with reduced spirometry at school-age in children with cystic fibrosis (CF) Source: Annual Congress 2013 –Cystic fibrosis: lung function and change of lung function in infants and children before and after treatment Year: 2013 Diffuse lung disease and pulmonary hypertension related to TBX4 mutation in 5 children Source: International Congress 2019 – A mixture of rare lung diseases Year: 2019 Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry Source: Eur Respir J, 58 (2) 2101483; 10.1183/13993003.01483-2021 Year: 2021 Glycaemic variability indices are associated with increased pulmonary function decline in people with cystic fibrosis Source: International Congress 2018 – Cystic fibrosis: diagnosis and monitoring Year: 2018 Cardiovascular comorbidities based on impaired pulmonary function in non-smoking population Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 Outcome of pulmonary hypertension associated with respiratory disease Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019 Risk factors for the decline of pulmonary function among bronchiectasis patients in Japan Source: International Congress 2019 – Bronchiectasis Year: 2019 Diaphragm dysfunction in combination with lung function decline is associated with higher mortality in idiopathic pulmonary fibrosis patients Source: International Congress 2018 – Consequences of idiopathic interstitial pneumonias Year: 2018 Is survival in patients with severe group 3 pulmonary hypertension influenced by targeted therapy? Source: International Congress 2015 – Pulmonary hypertension: novel clinical insights Year: 2015 Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it. Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019 The prevalence of pulmonary hypertension and the related factors in hemodialysis patients Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach Year: 2012